Hot Pursuit     13-Mar-23
Alembic Pharma says USFDA clears Karakhadi facility
The drug maker announced that the US Food and Drug Administration (USFDA) successfully completed the inspection for its derma facility located at Karakhadi, Gujarat without any observations.
The inspection was conducted from 6th to 10th March 2023.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. The company manufactures and markets generic pharmaceutical products all over the world.

The drug maker reported 29% drop in consolidated net profit to Rs 121.92 crore despite a 18.7% rise in net sales to Rs 1509.02 crore in Q3 FY23 over Q3 FY22.

The scrip was down 0.85% to Rs 495.05 on the BSE.

Previous News
  Alembic Pharma gets USFDA nod for Doxycycline Capsules
 ( Hot Pursuit - 28-Jun-24   12:20 )
  Alembic Pharmaceuticals receives USFDA approval for Mesalamine ER Capsules
 ( Corporate News - 02-Nov-22   09:40 )
  Alembic Pharma reports turnaround Q1 numbers
 ( Hot Pursuit - 05-Aug-23   12:56 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 08-Jun-23   14:30 )
  Alembic Pharmaceuticals gets USFDA approval
 ( Corporate News - 27-Oct-22   11:52 )
  Alembic Pharmaceuticals receives EIR for its Injectable Facility at Karkhadi
 ( Corporate News - 16-Feb-23   15:25 )
  Alembic Pharma gains as Karkhadi facility gets EIR from USFDA
 ( Hot Pursuit - 16-Feb-23   15:42 )
  Alembic Pharmaceuticals JV receives USFDA final approval for Testosterone Gel
 ( Corporate News - 04-Mar-21   10:49 )
  Alembic Pharmaceuticals to acquire 40% stake in Aleor Dermaceuticals
 ( Corporate News - 29-Mar-22   15:41 )
  Alembic Pharma buys out Orbicular's stake in Aleor Dermaceuticals
 ( Hot Pursuit - 29-Mar-22   15:23 )
  Alembic Pharma
 ( Results - Analysis 30-Nov-21   20:00 )
Other Stories
  Nuvama Wealth Mgmt Q1 PAT jumps 79% YoY to Rs 221 cr
  27-Jul-24   16:44
  ICICI Bank Q1 PAT rises 15% YoY to Rs 11,059 cr
  27-Jul-24   15:38
  Punjab & Sind Bank Q1 PAT rises 19% YoY to Rs 181 cr
  27-Jul-24   14:42
  Bandhan Bank Q1 PAT climbs 47% to Rs 1,063 cr
  27-Jul-24   13:31
  BHEL receives LOI for Rs 10,000 crore project from Damodar Valley Corporation
  27-Jul-24   10:54
  Gujarat Themis' Q1 PAT falls over 25% YoY to Rs 13 crore
  27-Jul-24   09:25
  Power Grid Q1 PAT rises 3% YoY to Rs 3,724 cr
  27-Jul-24   08:54
  IndusInd Bank PAT rises to Rs 2,152 cr in Q1 FY25
  26-Jul-24   17:40
  Cipla spurts as Q1 PAT rises 18% YoY to Rs 1,178 cr
  26-Jul-24   15:53
  Shriram Finance soars as Q1 PAT rises 18% YoY
  26-Jul-24   15:33
Back Top